# Study of PXL065 in Patients With Nonalcoholic Steatohepatitis (NASH)

> **NCT04321343** · PHASE2 · COMPLETED · sponsor: **Poxel SA** · enrollment: 117 (actual)

## Conditions studied

- NASH - Nonalcoholic Steatohepatitis

## Interventions

- **DRUG:** PXL065
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04321343
- **Lead sponsor:** Poxel SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-01
- **Primary completion:** 2022-06-08
- **Final completion:** 2022-06-20
- **Target enrollment:** 117 (ACTUAL)
- **Last updated:** 2023-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04321343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04321343, "Study of PXL065 in Patients With Nonalcoholic Steatohepatitis (NASH)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04321343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*